September 29, 2026

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring the 22.64% Upside in Biotech Innovation

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has emerged as a compelling player in the biotechnology sector, boasting a market capitalization of $9.22 billion. Headquartered in Newark, California,..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 35% Upside Potential in the Biotech Sector

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is drawing significant attention in the biotechnology sector with its promising therapeutic pipeline and potential for robust growth. With its current..

Artivion, Inc. (AORT) Stock Analysis: A Strong Buy with 83% Upside Potential

Artivion, Inc. (AORT), a key player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking growth and value...

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Potential 74% Upside for Healthcare Investors

Brookdale Senior Living Inc. (NYSE: BKD) stands at a compelling crossroads for investors, particularly those with a focus on the healthcare sector. With a market cap..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a Significant 70.82% Potential Upside

In the dynamic landscape of healthcare technology, Omnicell, Inc. (NASDAQ: OMCL) emerges as a pivotal player. With a market capitalization of $1.54 billion, the company is..

SS Innovations International (SSII) Stock Analysis: A Potential 142% Upside in the Healthcare Sector

SS Innovations International, Inc. (SSII), a pioneering entity in the healthcare sector, specifically in medical devices, has captured investor attention with its innovative approach to surgical..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring the 3.21% Potential Upside

Pulse Biosciences, Inc (NASDAQ: PLSE), a healthcare innovator in the medical instruments and supplies industry, is garnering attention with its promising technologies and an attractive potential..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Navigating Market Volatility with Unique Product Offerings

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, specializes in the development, manufacturing, and marketing of both generic and proprietary injectable, inhalation,..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 111% Potential Upside in the Healthcare Sector

For investors keeping a keen eye on the medical device industry, Enovis Corporation (NYSE: ENOV) presents a compelling opportunity. With a substantial market cap of $1.05..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A 71.89% Potential Upside Sparks Investor Interest

Denali Therapeutics Inc. (NASDAQ: DNLI), a notable player in the biotechnology sector, is attracting significant attention from individual investors due to its promising portfolio targeting neurodegenerative..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Potential Upside of 94.67% for Biotech Innovator

Investors with an eye on the biotechnology sector might find Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) a compelling opportunity, given its focus on rare and ultra-rare genetic..

Neogen Corporation (NEOG) Stock Analysis: Evaluating Growth Potential in the Medical Devices Sector

Neogen Corporation (NASDAQ: NEOG), a pivotal player in the healthcare sector, specifically within the medical devices industry, offers a unique value proposition for investors focused on..

Haemonetics Corporation (HAE) Stock Analysis: A Strong Buy Signal with a 5.4% Upside Potential

Haemonetics Corporation (NYSE: HAE), a leader in the healthcare sector’s medical devices industry, is drawing significant attention from investors. With a solid market capitalization of $4.81..

AdaptHealth Corp. (AHCO) Stock Analysis: High Potential Upside with Strong Buy Consensus

AdaptHealth Corp. (NASDAQ: AHCO), a significant player in the healthcare sector specializing in medical devices, presents a compelling investment case for those looking at high potential..

GeneDx Holdings Corp. (WGS) Stock Analysis: Evaluating a Genomic Pioneer with a 5.25% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a leader in the genomics field, continues to capture investor attention with its innovative approach to genetic testing and diagnostics. As..

Kestra Medical Technologies (KMTS): A Compelling Growth Play with 7.66% Upside Potential

Investors seeking opportunities in the healthcare sector should pay close attention to Kestra Medical Technologies, Ltd. (KMTS), a company making significant strides in the medical instruments..

Vericel Corporation (VCEL): Investor Outlook on Strong Growth and 50% Upside Potential

As Vericel Corporation (NASDAQ: VCEL) continues to carve out its niche in the healthcare sector, the biotechnology firm presents an intriguing investment opportunity, particularly for those..

Addus HomeCare Corporation (ADUS) Investor Outlook: Analyzing the 19.46% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS) stands out in the healthcare sector, particularly in the medical care facilities industry, where it operates as a pivotal provider of..

Teladoc Health, Inc. (TDOC) Investor Outlook: Exploring a 30% Upside Potential Amidst Healthcare Innovation

Teladoc Health, Inc. (NYSE: TDOC), a pioneer in virtual healthcare services, offers investors a compelling case for potential upside amidst the evolving landscape of digital health...

AtriCure, Inc. (ATRC) Stock Analysis: Growth Potential in the Surgical Ablation Market

AtriCure, Inc. (NASDAQ: ATRC) stands out in the healthcare sector as a key player in the medical instruments and supplies industry, with a primary focus on..

Search

Funds

September 29, 2026

Search

Funds

September 29, 2026

FTSE 100

Funds